Cargando…
Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review
BACKGROUND: Levomepromazine is an antipsychotic drug that is used clinically for a variety of distressing symptoms in palliative and end-of-life care. We undertook a systematic review based on the question “What is the published evidence for the use of levomepromazine in palliative symptom control?”...
Autores principales: | Dietz, Isabel, Schmitz, Andrea, Lampey, Ingrid, Schulz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602665/ https://www.ncbi.nlm.nih.gov/pubmed/23331515 http://dx.doi.org/10.1186/1472-684X-12-2 |
Ejemplares similares
-
Crystal structure of levomepromazine maleate
por: Gál, Gyula Tamás, et al.
Publicado: (2016) -
Levomepromazine: Delirium and sedation: case report
Publicado: (2021) -
The effect of levomepromazine on the healthy and injured developing mouse brain – An in vitro and in vivo study
por: Posod, Anna, et al.
Publicado: (2020) -
Evaluation of the palliative symptom burden score (PSBS) in a specialised palliative care unit of a university medical centre - a longitudinal study
por: Fetz, Katharina, et al.
Publicado: (2018) -
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
por: Suzuki, Hidenobu, et al.
Publicado: (2013)